Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ryan

Showing results (961-970 of 989) with videos related to

Pageof 99
Sort By:
The Journal of Clinical Investigation|April 16, 2013
MERTK receptor tyrosine kinase is a therapeutic target in melanomaJennifer Schlegel, Maria J Sambade, Susan Sather, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2017
Direct measurements of meltwater runoff on the Greenland ice sheet surfaceLaurence C Smith, Kang Yang, Lincoln H Pitcher, et al.
Papua and New Guinea Medical Journal|February 6, 2014
Male circumcision for HIV prevention in Papua New Guinea: a summary of research evidence and recommendations for public health following a national policy forumA Vallely, D J MacLaren, W Kaleva, et al.
Cell Genomics|June 26, 2024
Gene-environment interactions within a precision environmental health frameworkAlison A Motsinger-Reif, David M Reif, Farida S Akhtari, et al.
JCI Insight|October 10, 2023
GADD45A is a mediator of mitochondrial loss, atrophy, and weakness in skeletal muscleGeorge R Marcotte, Matthew J Miller, Hawley E Kunz, et al.
Plos Genetics|September 15, 2010
The characterization of twenty sequenced human genomesKimberly Pelak, Kevin V Shianna, Dongliang Ge, et al.
Neuro-Oncology|April 6, 2017
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastomaRobert S McNeill, Demitra A Canoutas, Timothy J Stuhlmiller, et al.
Mabs|July 8, 2025
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studiesFrank R Brennan, J Ryan Polli, Jean Sathish, et al.
Acta Neuropathologica Communications|June 28, 2025
Identifying and exploiting combinatorial synthetic lethality by characterizing adaptive kinome rewiring of EGFRvIII-driven glioblastomaBenjamin Lin, Abigail K Shelton, Erin Smithberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2011
High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinomaMei-Kim Ang, Mihir R Patel, Xiao-Ying Yin, et al.
Pageof 99

Showing results (961-970 of 989) with videos related to

Sort By:
Pageof 99
The Journal of Clinical Investigation|April 16, 2013
MERTK receptor tyrosine kinase is a therapeutic target in melanomaJennifer Schlegel, Maria J Sambade, Susan Sather, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2017
Direct measurements of meltwater runoff on the Greenland ice sheet surfaceLaurence C Smith, Kang Yang, Lincoln H Pitcher, et al.
Papua and New Guinea Medical Journal|February 6, 2014
Male circumcision for HIV prevention in Papua New Guinea: a summary of research evidence and recommendations for public health following a national policy forumA Vallely, D J MacLaren, W Kaleva, et al.
Cell Genomics|June 26, 2024
Gene-environment interactions within a precision environmental health frameworkAlison A Motsinger-Reif, David M Reif, Farida S Akhtari, et al.
JCI Insight|October 10, 2023
GADD45A is a mediator of mitochondrial loss, atrophy, and weakness in skeletal muscleGeorge R Marcotte, Matthew J Miller, Hawley E Kunz, et al.
Plos Genetics|September 15, 2010
The characterization of twenty sequenced human genomesKimberly Pelak, Kevin V Shianna, Dongliang Ge, et al.
Neuro-Oncology|April 6, 2017
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastomaRobert S McNeill, Demitra A Canoutas, Timothy J Stuhlmiller, et al.
Mabs|July 8, 2025
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studiesFrank R Brennan, J Ryan Polli, Jean Sathish, et al.
Acta Neuropathologica Communications|June 28, 2025
Identifying and exploiting combinatorial synthetic lethality by characterizing adaptive kinome rewiring of EGFRvIII-driven glioblastomaBenjamin Lin, Abigail K Shelton, Erin Smithberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2011
High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinomaMei-Kim Ang, Mihir R Patel, Xiao-Ying Yin, et al.
Pageof 99